Leaderna Therapeutics

Chengdu, China · Founded 2022 · Privately Held (backing)

Developer of nucleic acid-based therapeutic research designed to advance targeted biological interventions. Leaderna Therapeutics is based in Chengdu, China and was founded in 2022. Its last reported valuation was $33.9 million in Dec 2022. It has raised $44.9 million.

Last reported valuation
$33.9M
Oct 2026
Priced at
—
Total raised
$44.9M
Last round
—

Who backs Leaderna Therapeutics?

14 investors
InvestorType
CAS StarOther
CDH InvestmentsPE / buyout
Sky9 CapitalVenture capital
Chengdu Venture Capital GroupOther
Tianjin Venture CapitalVenture capital
Chengdu Bio-Town InvestmentOther
Xiamen Hi-Tech Innovation CenterOther
Caleb Capital—
Daoyuan Capital—
HitGen—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Leaderna Therapeutics investors

14 investors are on record for Leaderna Therapeutics, including CAS Star, CDH Investments, Sky9 Capital and Chengdu Venture Capital Group.

Free account
More of Leaderna Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Leaderna Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Leaderna Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View